Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. EVGN.NASDAQ

Evogene (EVGN NASDAQ) stock market data APIs

$4.8 -0.34(-6.6%) as of July 26, 2024
Price chart is built with Anychart

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Evogene Financial Data Overview

5.14
4.8
-
5.14
4.79
4.502-11
312 M
5 079 K
9 189 K
-0.08
1.066
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EVGN',
Type: 'Common Stock',
Name: 'Evogene',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000TGYG90',
ISIN: 'IL0011050551',
CUSIP: 'M4119S104',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2008-03-05',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Evogene Fundamental Data is available in our Financial Data APIs

  • Net Revenue 9 189 K
  • EBITDA -21 442 000
  • Earnings Per Share -0.45
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Evogene Earnings via APIs

  • Latest Release 2024-05-23
  • EPS/Forecast -0.09

Get Evogene End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Evogene latest news via APIs

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leadi...

Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript

Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript March 7, 2024 Evogene Ltd. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here)...
Do you have any questions?
support@eodhistoricaldata.com